Anpario (LON:ANP) Hits New 1-Year High – Here’s Why

Anpario plc (LON:ANP)’s stock price hit a new 52-week high on Monday . The company traded as high as GBX 437 ($5.34) and last traded at GBX 431.60 ($5.27), with a volume of 124569 shares. The stock had previously closed at GBX 407.66 ($4.98).

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Canaccord Genuity Group raised their price objective on shares of Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the stock a “buy” rating in a report on Wednesday, September 18th. Canaccord Genuity Group raised their price target on shares of Anpario from GBX 380 ($4.64) to GBX 500 ($6.10) and gave the stock a “buy” rating in a research note on Tuesday.

Anpario Price Performance

The firm has a 50 day moving average price of GBX 362.62 and a two-hundred day moving average price of GBX 322.22. The company has a market cap of £74.21 million, a P/E ratio of 2,437.92 and a beta of 0.58. The company has a debt-to-equity ratio of 0.21, a quick ratio of 5.16 and a current ratio of 6.15.

Insider Buying and Selling at Anpario

In other news, insider Karen Prior sold 14,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.64), for a total value of £53,200 ($64,949.33). Insiders own 30.51% of the company’s stock.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.